Breaking News

Close

Gyre Therapeutics Inc (GYRE)

Add to/Remove from Watchlist Add to Watchlist

15.8400 -0.1600 -1.00%

- Closed. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

Volume: 41,983
Bid/Ask: 0.0000 / 0.0000
Day's Range: 15.2558 - 16.4200

NASDAQ:GYRE Financials

A brief overview of the NASDAQ:GYRE financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Targacept over time.

Gyre Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 113.45 million compared to USD 102.29 million a year ago. Net loss was USD 92.93 million compared to net income of USD 2.3 million a year ago. Basic loss per share from continuing operations was USD 1.41 compared to basic earnings per share from continuing operations of USD 0.04 a year ago. Diluted loss per share from continuing operations was USD 1.41 compared to diluted earnings per share from continuing operations of USD 0.03 a year ago.

Annual Quarterly

InvestingPro

Advanced Financial Summary

TTM = Trailing Twelve Months

MRQ = Most Recent Quarter

GYRE Income Statement

Gross margin TTM 95.91%

Operating margin TTM 16.94%

Net Profit margin TTM -81.92%

Return on Investment TTM 15.7%

Total Revenue Net Income

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue	29.98	30.74	189.63	189.63
Gross Profit	28.73	29.46	182.05	182.05
Operating Income	2.27	2.47	52.04	52.04
Net Income	-52.19	-52.03	40.6	40.6

GYRE Balance Sheet

Quick Ratio MRQ 2.43

Current Ratio MRQ 2.85

LT Debt to Equity MRQ 0%

Total Debt to Equity MRQ -2.58%

Total Assets Total Liabilities

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets	116.54	116.54	806.62	806.62
Total Liabilities	38.06	38.06	98.81	98.81
Total Equity	78.47	78.47	707.81	707.81

GYRE Cash Flow Statement

Cash Flow/Share TTM 0

Revenue/Share TTM 0

Operating Cash Flow 0.00%

Cash Net Change in Cash

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Period Length:	0 Months	0 Months	0 Months	0 Months
Cash From Operating Activities		4.28	63.24	63.24
Cash From Investing Activities		0	-64.55	-64.55
Cash From Financing Activities		-1.48	-0.953	-0.953
Net Change in Cash		-4.7	-2.27	-2.27

* In Millions of USD (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

GYRE Comments

Write your thoughts about Gyre Therapeutics Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Nov 15, 2021 8:42PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

needs better leadership

0 0

Duane Goodson Jan 04, 2021 11:51AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.

0 0

Alex Levin Nov 20, 2020 1:24PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

hope that in long term it will rise

0 0

Episcopolian1 Sep 15, 2017 11:40AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Phase 1/2 completion of dosing announced June 14, 2017 with data due by the end of September.. Data will be excellent! The stock will rock once again!

0 0

Al Trader Sep 14, 2017 5:09AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

To holders of CBIO: Patience will pay off. Between now and December we should have a major event that would restore the fair price to this stock.

1 0

Episcopolian1 Sep 13, 2017 10:58AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Catalyst Biosciences Announces Issuance of Asia Patents Covering Factor IX Hemophilia Program. . 8:01 am ET September 11, 2017 (Globe Newswire) Print

0 0

Al Trader Sep 13, 2017 9:25AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

CBIO is warming up to something. Maybe good news is in the way. I feel something good is coming

0 0

Al Trader Sep 11, 2017 1:02PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

why are you selling your shares cheep. Some one is accumulating for the big day.

0 0

Episcopolian1 Jul 05, 2017 3:59PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Watch out for $CBIO as secondary offering lock-up expires tomorrow 7/6/17

0 0

Episcopolian1 Mar 28, 2017 12:09PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Something I read from an analyst opinion column today about this . . This is a great news for $CBIO for being able to partner with "ISU Abxis"ISU Abxis is the beggest Biotech ion Korea with annual revenue of $30B.. Furthermore, they are doing some fantastic blood cancer work. If they agreed to $CBIO data, that means something....

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="201243953">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="201243953" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="201243953" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="201243953">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	37,784.8	+31.5	+0.08%
	US 500	5,030.1	+7.9	+0.16%
	Dow Jones	37,753.31	-45.66	-0.12%
	S&P 500	5,022.21	-29.20	-0.58%
	Nasdaq	15,683.37	-181.88	-1.15%
	S&P 500 VIX	18.21	-0.19	-1.03%
	Dollar Index	105.800	+0.030	+0.03%

	Crude Oil WTI	82.75	+0.06	+0.07%
	Brent Oil	87.43	-0.10	-0.11%
	Natural Gas	1.738	+0.017	+0.99%
	Gold	2,382.50	-5.90	-0.25%
	Silver	28.310	-0.090	-0.32%
	Copper	4.3347	-0.0063	-0.15%
	US Soybeans	1,146.00	-3.25	-0.28%

	U.S. 10Y	4.580	-0.004	-0.09%
	U.S. 30Y	4.695	-0.004	-0.09%
	U.S. 5Y	4.606	-0.011	-0.24%
	U.S. 3M	5.430	+0.041	+0.76%
	US 10Y T-Note	108.19	+0.03	+0.03%
	Euro Bund	131.61	+0.11	+0.08%
	10-2 Yield Spread	-31.76	-0.04	0.13%

	Apple	168.00	-1.38	-0.81%
	Alphabet A	155.47	+1.07	+0.69%
	Tesla	155.45	-1.66	-1.06%
	Amazon.com	181.28	-2.04	-1.11%
	Netflix	613.69	-3.83	-0.62%
	Meta Platforms	494.17	-5.59	-1.12%
	Bank of America	35.22	+0.54	+1.54%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GYRE	15.8400	-0.1600	-1.00%

	Name	Last	Chg. %	Vol.
	TSLA	155.45	-1.06%	78.83M
	AMD	154.02	-5.78%	74.70M
	NVDA	840.35	-3.87%	48.52M
	AAPL	168.00	-0.81%	47.79M
	MSFT	411.84	-0.66%	15.21M
	SMCI	960.08	-1.66%	7.10M
	BRKa	599,928	+0.30%	12.79K

	Name	Last	Chg. %	Vol.
	UAL	48.74	+17.45%	65.20M
	AAL	13.89	+6.60%	51.57M
	GL	63.20	+5.39%	4.83M
	DAY	61.34	+4.68%	1.90M
	PARA	10.81	+3.64%	10.19M
	NEE	63.79	+3.39%	15.23M
	ED	90.29	+3.28%	2.85M

	Name	Last	Chg. %	Vol.
	JBHT	168.13	-8.12%	3.61M
	TRV	206.67	-7.37%	5.28M
	PLD	106.50	-7.18%	9.74M
	ASML	907.61	-7.09%	3.70M
	RMD	173.86	-5.95%	2.97M
	ADSK	214.92	-5.84%	6.26M
	AMD	154.02	-5.78%	74.70M